Cardiac Wire #102 July 31, 2023
Tirzepatide’s Weight Loss Superiority | HeartFlow’s All-In-One Results
Cardiac Wire #101 July 27, 2023
Alnylam and Roche’s BP Alliance | ATTR-CM Progress and Promise
Cardiac Wire #100 July 24, 2023
Zilebesiran’s Long-Lasting BP Control | The Rise of Cardiology Private Equity
Cardiac Wire #99 July 20, 2023
Astellas’ Heart Failure DTx Solution | Heart Drugs Medicare Impact
Cardiac Wire #98 July 17, 2023
Lilly Diversifies Weight Loss Pipeline | CMS’ CAS Expansion Proposal
Cardiac Wire #97 July 13, 2023
Cholesterol Control Falls Short | Leqvio’s Primary Expansion
Cardiac Wire #96 July 10, 2023
Dissolvable Heart Monitor and Pacer | No SMuRFs’ Greater AMI Risks
Cardiac Wire #95 July 6, 2023
ECG AI for OMI Detection | More Weight Loss Advances
Cardiac Wire #94 June 29, 2023
Bempedoic Acid’s Primary Prevention Impact | Shopping Cart Afib Screening
Cardiac Wire #93 June 26, 2023
The Impella Pump’s Evidence Problem | The ICs Are Not Alright
Cardiac Wire #92 June 22, 2023
Lodoco’s CVD Inflammation Approval | Eclampsia Tragedy
Cardiac Wire #91 June 20, 2023
NYU’s Inflammation Discovery | False Atherectomy Claims
Cardiac Wire #90 June 15, 2023
Cardiologists’ Problem with NP-Led TAVI | Alcohol’s CVD Benefits
Cardiac Wire #89 June 12, 2023
Bitterroot Bio’s Cardio-Immunology Mission | CVD’s Musculoskeletal Link
Cardiac Wire #88 June 8, 2023
Questioning Antihypertensives | Obicetrapib’s LDL-C Impact
Cardiac Wire #87 June 5, 2023
Lexicon Lands HF FDA | NT‐proBNP Screening
Cardiac Wire #86 June 1, 2023
Wearable Cardiac Ultrasound Milestone | CAC Beats PRS
Cardiac Wire #85 May 25, 2023
Remote Cardiac Monitoring Momentum | HRS & ESC HF 2023
Cardiac Wire #84 May 22, 2023
